Zhangzhou Pientzehuang Pharmaceutical., Ltd Share Price

Equities

600436

CNE000001F21

Pharmaceuticals

End-of-day quote Shanghai S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
225.7 CNY +2.48% Intraday chart for Zhangzhou Pientzehuang Pharmaceutical., Ltd -0.15% -6.74%

Financials

Sales 2024 * 11.6B 1.6B 133B Sales 2025 * 13.23B 1.83B 152B Capitalization 136B 18.79B 1,567B
Net income 2024 * 3.35B 462M 38.53B Net income 2025 * 3.95B 545M 45.44B EV / Sales 2024 * 11.5 x
Net cash position 2024 * 2.41B 333M 27.73B Net cash position 2025 * 3.68B 508M 42.4B EV / Sales 2025 * 10 x
P/E ratio 2024 *
40.6 x
P/E ratio 2025 *
34.5 x
Employees 2,789
Yield 2024 *
1.14%
Yield 2025 *
1.12%
Free-Float 38.58%
More Fundamentals * Assessed data
Dynamic Chart
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. Signs Cooperation Agreement with Beijing Tong Ren Tang Group CI
Pientzehuang Pharmaceutical's Profit Climbs 12.6% in 2023 MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhangzhou Pientzehuang to Raise Price of Multifunctional TCM by 29% MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pientzehuang Logs Slowest Profit Growth in 12 Years MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pien Tze Huang Pharma’s Q3 Profit Falls 18% as Revenue Slips 3% MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
FTSE Russell makes additions including PetroChina in review of China indices RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+2.48%
1 week-0.15%
Current month-1.24%
1 month-2.25%
3 months-1.02%
6 months-10.04%
Current year-6.74%
More quotes
1 week
219.00
Extreme 219
234.50
1 month
216.48
Extreme 216.48
237.20
Current year
180.69
Extreme 180.69
242.98
1 year
180.69
Extreme 180.69
321.00
3 years
180.69
Extreme 180.69
491.88
5 years
90.96
Extreme 90.96
491.88
10 years
19.63
Extreme 19.6267
491.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 18/16/18
Director/Board Member 58 01/10/01
Director/Board Member 59 01/86/01
Members of the board TitleAgeSince
Director/Board Member 64 20/22/20
Chief Executive Officer 58 18/16/18
Director/Board Member 48 29/18/29
More insiders
Date Price Change Volume
26/24/26 225.7 +2.48% 2,728,491
25/24/25 220.2 -2.08% 2,566,988
24/24/24 224.9 -1.94% 1,801,985
23/24/23 229.4 +0.86% 1,820,343
22/24/22 227.4 +0.60% 2,366,916

End-of-day quote Shanghai S.E., April 26, 2024

More quotes
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is specialized in developing and marketing traditional Chinese medicine products. The company offers medicines and health products, cosmetic products, dietary compounds, etc.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
225.7 CNY
Average target price
285.6 CNY
Spread / Average Target
+26.56%
Consensus
  1. Stock Market
  2. Equities
  3. 600436 Stock